Harmonizing drugs standards in West Africa
The recent decision by the heads of National Medicine Regulatory Authorities (NMRA) and West African Economic Monetary Union (WAEMU), to hasten the harmonization of drugs standards in West Africa is laudable against the backdrop of the region's quest for unity and a common destiny, meaning that what affects one country affects the others.
Without adequate regulation, the free movement of counterfeit and fake drugs within the sub-region poses a great danger to the people, reported Nigeria’s The Guardian newspaper.
A weak regulation would also rubbish whatever progress is made in any of the 15-member Economic Community of West African States (ECOWAS) countries, hence the relevant authorities should set the necessary machinery in motion to ensure that the adopted proposal is faithfully implemented in the public interest.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze